Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Cash from financing is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders.
For the
six
months ended in Jun. 2025,
Apiam Animal Health paidA$0.0 Mil more to buy back shares than it received from issuing new shares.
It spentA$2.4 Mil paying down its debt.
It paidA$0.0 Mil more to buy back preferred shares than it received from issuing preferred shares.
It spentA$1.3 Mil paying cash dividends to shareholders.
It spentA$3.4 Mil on other financial activities.
In all, Apiam Animal HealthspentA$7.2 Mil on financial activities for the
six
months ended in Jun. 2025.
Apiam Animal Health (ASX:AHX) Cash Flow from Financing Explanation
Cash from financing contains six items:
1. Issuance of Stock:
A company may raise cash from issuing new shares. Issuance of stock represents the cash inflow from offering common stock, which is the additional capital contribution to the entity during the period.
Apiam Animal Health's issuance of stock for the
six
months ended in Jun. 2025 was A$0.0 Mil.
2. Repurchase of Stock:
A company may raise cash from issuing new shares. It can also use cash to buy back shares. Repurchase of stock represents the cash outflow to reacquire common stock during the period.
Apiam Animal Health's repurchase of stock for the
six
months ended in Jun. 2025 was A$0.0 Mil.
3. Net Issuance of Debt:
Net issuance of debt is the cash a company received or spent through debt related activities such as debt issuance or debt repayment. If a company pays down its debt during the period, this number will be negative. If a company issued more debt, it receives cash and this number is positive.
Apiam Animal Health's net issuance of debt for the
six
months ended in Jun. 2025 was A$-2.4 Mil.
Apiam Animal Health spentA$2.4 Mil paying down its debt.
4. Net Issuance of Preferred Stock:
A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares. If this number is positive, it means that the company has received more cash from issuing preferred shares than it has paid to buy back preferred shares. If this number is negative, it means that company has paid more cash to buy back preferred shares than it has received for issuing preferred shares.
Apiam Animal Health's net issuance of preferred for the
six
months ended in Jun. 2025 was A$0.0 Mil.
Apiam Animal Health paidA$0.0 Mil more to buy back preferred shares than it received from issuing preferred shares.
5. Cash Flow for Dividends:
Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.
Apiam Animal Health's cash flow for dividends for the
six
months ended in Jun. 2025 was A$-1.3 Mil.
Apiam Animal Health spentA$1.3 Mil paying cash dividends to shareholders.
6. Other Financing:
Money spent or earned by company from other financial activities.
Apiam Animal Health's other financing for the
six
months ended in Jun. 2025 was A$-3.4 Mil.
Apiam Animal Health spentA$3.4 Mil on other financial activities.
Apiam Animal Health Cash Flow from Financing Related Terms
Apiam Animal Health Cash Flow from Financing Historical Data
* Premium members only.
The historical data trend for Apiam Animal Health's Cash Flow from Financing can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Apiam Animal Health Cash Flow from Financing Chart
Apiam Animal Health Cash Flow from Financing Calculation
This is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders. In the calculation of free cash flow, cash from financing is not calculated because it is not related to operating activities.
Apiam Animal Health's Cash from Financing for the fiscal year that ended in Jun. 2025 is calculated as:
Cash Flow from Financing for the trailing twelve months (TTM) ended in Jun. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$-10.6 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Cash Flow from Financing of A$-10.6 Mil mean?
Apiam Animal Health (ASX:AHX) has a Cash Flow from Financing of A$-10.6 Mil as of Jun. 2025. Cash Flow from Financing is the amount of cash earned or paid from financing operations. View historical data for Apiam Animal Health and its competitors.
Is Apiam Animal Health's Cash Flow from Financing too high?
Apiam Animal Health's current Cash Flow from Financing is A$-10.6 Mil. Overall, Apiam Animal Health has a GF Score™ of 50/100, reflecting its overall financial health beyond just this single metric.
How does Apiam Animal Health's Cash Flow from Financing compare to ROL and SCI?
Apiam Animal Health's Cash Flow from Financing of A$-10.6 Mil can be compared against companies in the Personal Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Flow from Financing for a Personal Services company?
A good Cash Flow from Financing depends on the Personal Services industry context. However, Cash Flow from Financing should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Flow from Financing mean?
A high Cash Flow from Financing can signal that a stock is expensive relative to its fundamentals. Cash Flow from Financing is the amount of cash earned or paid from financing operations. View historical data for Apiam Animal Health and its competitors. Apiam Animal Health's current Cash Flow from Financing is A$-10.6 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Apiam Animal Health stock overvalued right now?
Apiam Animal Health (ASX:AHX) has a current Cash Flow from Financing of A$-10.6 Mil. The stock's GF Value™ is A$0.40, compared to a current price of A$0.88 — trading 118.8% above its estimated fair value. The current Cash Flow from Financing is A$-10.6 Mil. Apiam Animal Health's overall GF Score™ is 50/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Flow from Financing calculated?
Cash Flow from Financing is calculated from a company's financial statements. For Apiam Animal Health (ASX:AHX), the current Cash Flow from Financing is A$-10.6 Mil as of Jun. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Apiam Animal Health (ASX:AHX) Overvalued in 2026?
Based on GuruFocus' analysis, Apiam Animal Health stock appears to be overvalued.
The current stock price of A$0.88 is trading 118.8% above its estimated GF Value™ of A$0.40.
Key valuation signals for ASX:AHX:
Cash Flow from Financing: A$-10.6 Mil
GF Value™: A$0.40 vs. price of A$0.88 (118.8% above fair value)
No single metric tells the full story. See the ASX:AHX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Apiam Animal Health Ltd provides products and services to support the health and welfare of production and mixed animals. The company offers veterinary wholesale, warehousing, logistics, and other ancillary services. Its operating segments include Dairy and Mixed, Feedlots and Pigs. It generates the majority of its revenue from Dairy and Mixed. The Group operates in the segment of provision of veterinary products and services to production, companion and equine animals.
50GF Score
Get the complete analysis for ASX:AHX
Cash Flow from Financing is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:AHX has been successfully added to your 
